Table 2.
Summary data for autograft studies.
| Study | Resection (cm) | Graft type | N | Age (y) | F-U (m) | Hardware issues | Fractures | Infections | PSA | Failures | MSTS score |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Kumar et al. [61] | 14 | (Arthrodesis) FVFG | 4 | 24 | 51 | 4% (1) | 0 | 4% (1) | 0 | 0 | — |
| Mimata et al. [62] | — | (Arthrodesis) FVFG | 5 | 21 | 75 | 0 | 40% (2) | 0 | 0 | 0 | 21.4 |
| Bilgin [63] | — | FVFG | 9 | 38 | 60 | 22% (2) | 11% (1) | 11% (1) | 0 | 0 | 24 |
| Manfrini et al. [64] | 13 | FVFG | 11 | 5 | 110 | 0 | 64% (7) | 9% (1) | 22.9 | ||
| Wada et al. [14] | 20 | FVFG | 8 | 27 | 70 | 0 | 0 | 0 | 12% (1) | 12% (1) | 23.7 |
| Li et al. [65] | — | Allograft + FVGF | 6 | 16 | 19 | 0 | 0 | 0 | 0 | 0 | 28 |
| Liu et al. [29] | — | TBIR + FVFG | 16 | 32 | 62 | 0 | 6% (1) | 0 | 25% (4) | 25% (4) | 19 |
| Amin and Ebeid [66] | 14 | Scapular pillar autograft | 16 | 21 | 36 | 0 | 0 | 0 | 12% (2) | 12% (2) | 22.5 |
| Padiolleau et al. [67] | 12 | Scapular pillar autograft | 12 | 36 | 59 | 0 | 0 | 0 | 25% (3) | 25% (3) | 21.3 |
| Barbier et al. [68] | 9 | CPH autograft | 7 | 8–18 | 40 | 14% (1) | 29% (2) | 0 | 71% (5) | 71% (5) | 21.7 |
| Calvert et al. [69] | 14 | CPH autograft | 4 | 6 | 43 | 0 | 0 | 0 | 50% (2) | 50% (2) | 26-27 |
| Kitagawa et al. [27] | — | CPH autograft | 7 | 29 | 18 | 0 | 0 | 0 | 0 | 0 | 21.5 |
| Rödl et al. [28] | — | CPH autograft | 15 | 18 | 59 | 0 | 22% (4) | 22% (4) | 22% (4) | 22% (4) | 24.6 |
| Tsukushi et al. [70] | — | CPH autograft | 7 | 36 | 26 | 14% (1) | 0 | 0 | 0 | 0 | 20.7 |
N, patients' number; F-U, follow-up; PSA, pseudoarthrosis (nonunion/severe union delay); FVFG, free vascularized fibular graft; CPH, clavicula pro humero.